In our fund agreements is incorporated explicitly that the portfolio companies shall not be engaged, directly or indirectly, in:
·production of and trade in weapons and ammunition; ·casinos and equivalent enterprises; ·production of and trade in tobacco and distilled alcoholic beverages and related products; ·human cloning for reproduction purposes; or ·research, development or technical applications relating to electronic data programs or solutions, which aim specifically at: (1)supporting any activity included in the restricted sectors referred to above; (2)internet gambling and online casinos; or (3)pornography, or which
are intended to enable to illegally: (1) enter into electronic data networks; or (2) download electronic data.
When providing financing to the research, development or technical applications relating to (i) human cloning for research or therapeutic purposes; or (ii) genetically modified organisms ("GMOs"), the Fund shall guarantee specific compliance with European Union legislation on GMOs and provide ethical guidelines and/or foresee appropriate monitoring procedures regarding such Investments.
Our portfolio companies have to confirm this on a bi-annually basis.